Cargando…
Chemotherapy in combination with pembrolizumab and antiangiogenesis in young patients with advanced primary pulmonary mucinous adenocarcinoma: Two case reports
Primary pulmonary mucinous adenocarcinoma is an unusual histological type of non-small cell lung cancer and has a rare prevalence at a young age. There is no standard first-line therapy for advanced primary pulmonary mucinous adenocarcinoma in children and young adults—this study reports two rare ca...
Autores principales: | Zhou, Daibing, Gulinuer, Wumaier, Zhu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461373/ https://www.ncbi.nlm.nih.gov/pubmed/34842490 http://dx.doi.org/10.1177/00368504211061971 |
Ejemplares similares
-
Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis
por: Wang, Ji, et al.
Publicado: (2016) -
EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma
por: Yiminniyaze, Ruzetuoheti, et al.
Publicado: (2022) -
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer
por: Jones, P H, et al.
Publicado: (2004) -
Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Lu, Heming, et al.
Publicado: (2022) -
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
por: Li, Song, et al.
Publicado: (2023)